NovaBridge Biosciences (NBP) Work In Process (2020 - 2022)

NovaBridge Biosciences (NBP) has reported Work In Process for 3 consecutive years, with $43.5 million the latest figure, recorded in Q2 2022.

• Quarterly Work In Process changed N/A year-over-year to $43.5 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $43.5 million (changed N/A YoY) and the FY2021 annual result came in at $39.8 million, up 14.28% from the prior year.
• Work In Process climbed to $43.5 million in Q2 2022 per NBP's latest filing, from $39.7 million in the prior quarter.
• Over the last five years, Work In Process for NBP reached as high as $43.5 million in Q2 2022 and fell as low as $34.3 million in Q4 2020.
• A 3-year average of $39.2 million and a median of $39.7 million in 2021 frame the typical range for Work In Process.
• The largest YoY upside for Work In Process was 15.69% in 2021 against a maximum downside of 15.69% in 2021.
• Year by year, Work In Process stood at $34.3 million in 2020, then advanced by 15.69% to $39.7 million in 2021, then climbed by 9.48% to $43.5 million in 2022.
• According to Business Quant data, Work In Process over the past three periods registered $43.5 million, $39.7 million, and $34.3 million for Q2 2022, Q4 2021, and Q4 2020 respectively.